Contact Us

Fimlab Laboratories expands the use of Aiforia’s AI solutions for breast cancer diagnostics, bringing multi-organ Ki67 biomarker quantification into routine clinical use. Aiforia Technologies Plc, Press Release, April 27, 2026 at 9:00 a.m....

CAMBRIDGE, UK — April 21, 2026 — Panakeia (“the Company”), the world’s first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual...

Using Aiforia Create, the laboratory La Fontana aims to develop deep learning AI models for analyzing cervical cancer samples. Aiforia Technologies Plc, Press Release, April 23, 2026, at 11:00 a.m. EEST Aiforia Technologies Plc has signed...